Mon - Fri 09:00-18:00 0207 060 3773
Email info@boundarycapital.com

Month

March 2020
Check out our new Impact Fund in the FT. Our new Life Impact Fund has been featured in FT Adviser. Ideal for private investors, the fund’s purpose is to ‘enrich people’s lives’. Target investments are businesses with disruptive technologies that have the potential to positively impact at least 100 million human lives, as well as...
Read More
Inotec AMD, a Cambridge based, fast-growing medtech business that has developed a novel device capable of healing complex chronic wounds, has secured investment of £7m. The funding round wasled by Praetura Capital, with involvement from Boundary Capital Partners LLP. The business has developed a world leading medtech product, called NATROX® Oxygen, for use in Wound...
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases